Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Збережено в:

Бібліографічні деталі
Співавтор:	Council for International Organizations of Medical Sciences (CIOMS)
Формат:	Книга
Мова:	English
Опубліковано:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Предмети:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Онлайн доступ:	Visit NHRC Library
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

Martindale: the complete drug reference
за авторством: Parfitt, Kathleen
Опубліковано: (1999)

WHO drug information.
Опубліковано: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Опубліковано: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Опубліковано: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Опубліковано: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Опубліковано: (2012)

USP DI. Approved drug products and legal requirements.
Опубліковано: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
за авторством: Andersson, Sarah
Опубліковано: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Опубліковано: (1997)

Pharmacology : a patient-centered nursing process approach /
за авторством: Kee, Joyce LeFever, та інші

Drug calculations : ratio and proportion problems for clinical practice /
за авторством: Seltzer, Meta Brown, та інші

Effective drug regulation a multicountry study /
за авторством: Ratanawijitrasin, Sauwakon
Опубліковано: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
за авторством: DEVS Consult Nepal (P) Ltd.
Опубліковано: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
за авторством: Acharya,Kiran
Опубліковано: (2018)

Regulatory Situation of Herbal Medicines
Опубліковано: (1998)

A text book of pharmacognosy.
за авторством: Raut, Bechan, та інші
Опубліковано: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
за авторством: Adhikari, SM, та інші
Опубліковано: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Опубліковано: (2012)

AHFS drug information 2000
за авторством: Snow, Elaine, K
Опубліковано: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Опубліковано: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
за авторством: Nepal Health Research Council (NHRC), та інші
Опубліковано: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
за авторством: Yadav, Raju
Опубліковано: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Опубліковано: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
за авторством: Brody, Tom
Опубліковано: (2016)

Evaluation of certain veterinary drug residues in food
Опубліковано: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
за авторством: Aryal, BK, та інші
Опубліковано: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
за авторством: Pande, Sarala
Опубліковано: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
за авторством: Adhikari, Shyam Mani
Опубліковано: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
за авторством: Adhikari, Shyam Mani, Dr.
Опубліковано: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Опубліковано: (1995)

Fundamentals of Clinical Trials /
за авторством: Friedman, Lawrence M, та інші
Опубліковано: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Опубліковано: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Опубліковано: (2000)

Drug policy in the Americas
за авторством: Smith, Peter H.
Опубліковано: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Опубліковано: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Опубліковано: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
за авторством: Poudel, Krishna Prasad
Опубліковано: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
за авторством: Maskay, NM, та інші
Опубліковано: (2016)